D. Fyfe
Clinical Trial Investigators(US)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.(1996)
- → Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial(2013)601 cited
- → Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial(2014)329 cited
- → Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer(2011)315 cited
- → Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer(2021)183 cited
- → Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer(2017)138 cited
- → Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.(1998)105 cited
- → Impact of neutropenia on delivering planned chemotherapy for solid tumours(2007)38 cited
- → 6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)(2009)31 cited
- → An exploratory, interview study of oncology patients' and health‐care staff experiences of discussing resuscitation(2007)18 cited